ACTIVITY OF ANTITUBERCULOSIS DRUGS AGAINST MYCOBACTERIUM LEPRAE.
D010131:Aminosalicylic Acid; D000636:Aminosalicylic Acids; D000818:Animals; D000995:Antitubercular Agents; D003523:Cycloserine; D003622:Dapsone; D007538:Isoniazid; D007918:Leprosy; D051379:Mice; D009166:Mycobacterium leprae; D009169:Mycobacterium tuberculosis; D010600:Pharmacology; D010619:Phenazines; D012106:Research; D013307:Streptomycin; D013882:Thiosemicarbazones
D000636:Aminosalicylic Acids; D000995:Antitubercular Agents; D010619:Phenazines; D013882:Thiosemicarbazones; D010131:Aminosalicylic Acid; D003622:Dapsone; D003523:Cycloserine; D007538:Isoniazid; D013307:Streptomycin
AMINOSALICYLIC ACID; ANTITUBERCULAR AGENTS; CYCLOSERINE; DAPSONE; EXPERIMENTAL LAB STUDY; ISONIAZID; LEPROSY; MICE; MYCOBACTERIUM LEPRAE; MYCOBACTERIUM TUBERCULOSIS; PHARMACOLOGY; PHENAZINES; STREPTOMYCIN; THIOSEMICARBAZONES